Web-based references relating to the number under the disk sign
1 Integrated medicine
[Link]; page 241
2 "The Spirit of Inquiry" by Sholem Glaser published by Alan Sutton in 1995. ISBN 07509 09986. HYPERLINK "http://www.jameslindlibrary.org/trial_records/17th_18th_Century/parry/parry_biog.html"
[Link]; page 241
3 Med J Aust. 1983 May 28;1(11):524-6. Dennerstein L. Psychosis and the menstrual cycle.
[Link]; page 241
4 Emotional aspects of endometriosis: a physician's perspective. Author: Jones KP. Journal: Clin Obstet Gynecol; 1988 Dec ; 31(4):874-82. PubMed ID: 3229043.
[Link]; page 241
5 A definition of sexual health. Greenhouse P. BMJ; 1995 Jun 3 ; 310(6992):1468-9. PubMed ID: 7613294 A definition of sexual health. Greenhouse P. BMJ; 1995 Jun 3 ; 310(6992):1468-9. PubMed ID: 7613294">[Link]; page 243
6 Sexual dysfunction in the United States: prevalence and predictors. Laumann EO, JAMA; 1999 Feb 10 ; 281(6):537-44. PubMed ID: 10022110
[Link]; page 243
7 ABC of sexual health: female sexual problems I: loss of desire-what about the fun? Butcher J. BMJ; 1999 Jan 2 ; 318(7175):41-3. PubMed ID: 9872888
[Link]; page 243
8 The frequency of significant pathology in women attending a general gynaecological service for postcoital bleeding. Rosenthal ABJOG; 2001 Jan ; 108(1):103-6. PubMed ID: 11212982
[Link]; page 250
9 International Diabetes Federation and Cite this article as: BMJ, doi:10.1136/bmj.38429.473310.AE 2005 April
[Link]; page 252
10 Laparoscopic ovarian drilling as first line of treatment in infertile women with polycystic ovary syndrome. Author: Cleemann L, Lauszus FF, Trolle B. Journal: Gynecol Endocrinol; 2004 Mar ; 18(3):138-43. PubMed ID: 15255282. Laparoscopic ovarian drilling as first line of treatment in infertile women with polycystic ovary syndrome. Author: Cleemann L, Lauszus FF, Trolle B. Journal: Gynecol Endocrinol; 2004 Mar ; 18(3):138-43. PubMed ID: 15255282.">[Link]; page 252
11 Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. Schellenberg R. BMJ; 2001 Jan 20 ; 322(7279):134-7. PubMed ID: 11159568
[Link]; page 254
12 Link no longer available; page 256
13 Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. Author: Rodriguez C, Patel AV, Calle EE, Jacob EJ, Thun MJ. Journal: JAMA; 2001 Mar 21 ; 285(11):1460-5. PubMed ID: 11255422
[Link]; page 256
14 BJOG. 2000 Aug;107(8):1012-6. A comparison of 25 mg and 50 mg oestradiol implants in the control of climacteric symptoms following hysterectomy and bilateral salpingo-oophorectomy. Panay N
[Link]; page 257
15 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.Author: Rossouw JE, Women's Health Initiative Investigators . Journal: JAMA; 2002 Jul 17 ; 288(3):321-33. PubMed ID: 12117397
[Link]; page 257
16 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA; 2003 May 28 ; 289(20):2651-62. PubMed ID: 12771112
[Link]; page 257
17 Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice. Ankum WM, BMJ; 2001 Jun 2 ; 322(7298):1343-6. PubMed ID: 11387184
[Link]; page 260
18 Fertility following radical, conservative-surgical or medical treatment for tubal pregnancy: a population-based study.Bouyer J, BJOG; 2000 Jun ; 107(6):714-21. PubMed ID: 10847225
[Link]; page 263
19 Fertility outcome following combined methotrexate treatment of unruptured extrauterine pregnancy.Debby A BJOG; 2000 May ; 107(5):626-30. PubMed ID: 10826577
[Link]; page 263
20 Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. Author: Kulasingam SL, Myers ER. Journal: JAMA; 2003 Aug 13 ; 290(6):781-9. PubMed ID: 12915431
[Link]; page 272
21 Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus. Author: Corona Gutierrez CM, Tinoco A, Navarro T, Contreras ML, Cortes RR, Calzado P, Reyes L, Posternak R, Morosoli G, Verde ML, Rosales R. Journal: Hum Gene Ther; 2004 May ; 15(5):421-31. PubMed ID: 15144573.
[Link]; page 272
22 Ultrasonographic measurement of endometrial changes following discontinuation of tamoxifen treatment in postmenopausal breast cancer patients. Cohen I, Beyth Y, Azaria R, Flex D, Figer A, Tepper R. BJOG; 2000 Sep ; 107(9):1083-7. PubMed ID: 11002949
[Link]; page 274
23 Reproductive health and polycystic ovary syndrome. Gibson M. Am J Med; 1995 Jan 16 ; 98(1A):67S-75S. PubMed ID: 7825642
[Link]; page 278
24 Br J Obstet Gynaecol. 1999 Jul;106(7):623-32. Spencer CP. Endometrial assessment re-visited.
[Link]; page 279
25 Dietary fat intake and risk of epithelial ovarian cancer: a meta-analysis of 6,689 subjects from 8 observational studies.Author: Huncharek M, Kupelnick B. Journal: Nutr Cancer; 2001 ; 40(2):87-91. PubMed ID: 11962260. Medline abstract, n=6,689 HYPERLINK "http://pubmedhh.nlm.nih.gov/cgi-bin/abstract.cgi?id=11962260&from=cqsr"
[Link]; page 280
26 Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.Author: Narod S. Journal: Lancet; 2001 May 12 ; 357(9267):1467-70. PubMed ID: 11377596.
[Link]; page 283
27 [No abstract] Bacterial vaginosis: a public health review. Morris M, Nicoll A, Simms I, Wilson J, Catchpole M. BJOG; 2001 May ; 108(5):439-50. PubMed ID: 11368127
[Link]; page 284
28 Evaluation of a new amplified enzyme immunoassay (EIA) for the detection of Chlamydia trachomatis in male urine, female endocervical swab, and patient obtained vaginal swab specimens. Author: Tanaka M, Nakayama H, Sagiyama K, Haraoka M, Yoshida H, Hagiwara T, Akazawa K, Naito S. Journal: J Clin Pathol; 2000 May ; 53(5):350-4. PubMed ID: 10889816.
[Link]; page 285
29 Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic. Author: Jensen JS, Bjšrnelius E, Dohn B, Lidbrink P. Journal: Sex Transm Dis; 2004 Aug ; 31(8):499-507. PubMed ID: 15273584.
[Link]; page 285
30 J Med Microbiol. 2002 Dec;51(12):1021-31.The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. Watson EJ
[Link]; page 285
31 Endometriosis. Author: Giudice LC, Kao LC. Journal: Lancet; 2004 Nov 13 ; 364(9447):1789-99. PubMed ID: 15541453
[Link]; page 288
32 Endometriosis during postmenopausal period--probable causes for its origin and development Author: Nikolov A, Dimitrov A, Iliev D, Genov N. Journal: Akush Ginekol (Sofiia); 2004 ; 43(6):50-3. PubMed ID: 15669654
[Link]; page 288
33 Stress reactivity and family relationships in the development and treatment of endometriosis. Author: Harrison V, Rowan K, Mathias J. Journal: Fertil Steril; 2005 Apr ; 83(4):857-64. PubMed ID: 15820791.
[Link]; page 288
34 Medical management of endometriosis-associated pain. Author: Mahutte NG, Arici A. Journal: Obstet Gynecol Clin North Am; 2003 Mar ; 30(1):133-50. PubMed ID: 12699262
[Link]; page 288
35 Medical management of endometriosis: a systematic review. Author: Schroder AK, Diedrich K, Ludwig M. Journal: IDrugs; 2004 May ; 7(5):451-63. PubMed ID: 15154107
[Link]; page 288
36 Current practice for the laparoscopic diagnosis and treatment of endometriosis: a national questionnaire survey of consultant gynaecologists in UK. Author: Moses SH, Clark TJ. Journal: BJOG; 2004 Nov ; 111(11):1269-72. PubMed ID: 15521873
[Link]; page 288
37 Origins and molecular pathology of ovarian cancer. Author: Bell DA. Journal: Mod Pathol; 2005 Feb ; 18 Suppl 2():S19-32. PubMed ID: 15761464
[Link]; page 288
38 International Journal of Gynecological Cancer Volume 13 Issue 4 Page 466 Endometriosis-related malignancies. G. S. Leiserowitz
[Link]; page 288
39 NIDA Res Monogr. 1984;44:46-64. Harclerode J. Endocrine effects of marijuana in the male: preclinical studies.
[Link]; page 295
40 Lancet. 1999 Aug 14;354(9178):566. Stanback J. Checklist for ruling out pregnancy among family-planning clients in primary care.
[Link]; page 297
41 Oral contraceptives and the risk of breast cancer.Author: Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG, Daling JR, Bernstein L, Malone KE, Ursin G, Strom BL, Norman SA, Wingo PA, Burkman RT, Berlin JA, Simon MS, Spirtas R, Weiss LK.Journal: N Engl J Med; 2002 Jun 27 ; 346(26):2025-32. PubMed ID: 12087137.
[Link]; page 300
42 Moreno V, Bosch FX, Mu–oz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S, International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group .Journal: Lancet; 2002 Mar 30 ; 359(9312):1085-92. PubMed ID: 11943255
[Link]; page 300
43 Combined oral contraceptives, migraine and ischaemic stroke. Clinical and Scientific Committee of the Faculty of Family Planning and Reproductive Health Care and the Family Planning Association. Author: MacGregor EA, Guillebaud J. Journal: Br J Fam Plann; 1998 Jul ; 24(2):55-60. PubMed ID: 9719712
[Link]; page 301
44 J Womens Health Gend Based Med. 2001 Jul-Aug;10(6):561-9. Freeman EW. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
[Link]; page 302
45 Mansour D 2005 Lancet 365 May 15 1670
[Link]; page 302
46 J Guillebaud 2004 Editorial in PoP reporter
[Link]; page 302
47 CNS Drugs. 2002;16(4):263-72. Crawford P. Interactions between antiepileptic drugs and hormonal contraception.
[Link]; page 304
48 N Engl J Med. 2000 Dec 7;343(23):1681-7. Related Articles, Links Comment in: N Engl J Med. 2000 Dec 7;343(23):1724-6. The risk of menstrual abnormalities after tubal sterilization. U.S. Collaborative Review of Sterilization Working Group--Peterson HB
[Link]; page 305
49 Vasectomy and the risk of prostate cancer: a meta-analysis examining vasectomy status, age at vasectomy, and time since vasectomy. Author: Dennis LK. Journal: Prostate Cancer Prostatic Dis; 2002 ; 5(3):193-203. PubMed ID: 12496981
[Link]; page 305
50 The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery. Author: MacLennan AH, Journal: BJOG; 2000 Dec ; 107(12):1460-70. PubMed ID: 11192101
[Link]; page 306
51 Managing incontinence due to detrusor instability. Journal: Drug Ther Bull; 2001 Aug ; 39(8):59-64. PubMed ID: 11526802
[Link]; page 306
52 Br J Obstet Gynaecol. 1999 Dec;106(12):1255-8. Pure stress leakage symptomatology: is it safe to discount detrusor instability?--James M
[Link]; page 306
53 RCOG Clinical Guidelines 35 2003 Surgical treatment for urodynamic stress incontinence
[Link]; page 306
54 Managing incontinence due to detrusor instability. Journal: Drug Ther Bull; 2001 Aug ; 39(8):59-64. PubMed ID: 11526802
[Link]; page 307
55 Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. Author: Cardozo L, Lisec M, Millard R, van Vierssen Trip O, Kuzmin I, Drogendijk TE, Huang M, Ridder AM. Journal: J Urol; 2004 Nov ; 172(5 Pt 1):1919-24. PubMed ID: 15540755.
[Link]; page 307
56 Managing incontinence due to detrusor instability. Journal: Drug Ther Bull; 2001 Aug ; 39(8):59-64. PubMed ID: 11526802
[Link]; page 307
57 Curr Opin Obstet Gynecol. 2001 Oct;13(5):507-12. Voiding dysfunction. Dorflinger A
[Link]; page 307
58 Detrusor myopathy: an accurate predictor of bladder hypocompliance and contracture in interstitial cystitis. Author: Christmas TJ, Smith GL, Rode J. Journal: Br J Urol; 1996 Dec ; 78(6):862-5. PubMed ID: 9014709
[Link]; page 307
59 Can ultrasound replace ambulatory urodynamics when investigating women with irritative urinary symptoms? Author: Robinson D, Anders K, Cardozo L, Bidmead J, Toozs-Hobson P, Khullar V. Journal: BJOG; 2002 Feb ; 109(2):145-8. PubMed ID: 11888096
[Link]; page 307
60 Sexuality after total vs. subtotal hysterectomy. Author: Zobbe V, Gimbel H, Andersen BM, Filtenborg T, Jakobsen K, S¿rensen HC, Toftager-Larsen K, Sidenius K, M¿ller N, Madsen EM, Vejtorp M, Clausen H, Rosgaard A, Gluud C, Ottesen BS, Tabor A. Journal: Acta Obstet Gynecol Scand; 2004 Feb ; 83(2):191-6. PubMed ID: 14756739
[Link]; page 308
Web-based references relating to the disc signs in footnotes, organised by page numberThe consequences of this go as deep as can be if we accept that our consciousness exists not as a story, nor as a teller of stories, but as one particular telling of many ambiguous stories. [No medline ref]; page 242
Use and offering of chaperones by general practitioners: postal questionnaire survey in Norfolk.Conway S, Harvey I. BMJ; 2005 Jan 29 ; 330(7485):235-6. PubMed ID: 15604154
[Link]; page 242
Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Marjoribanks J. Cochrane Database Syst Rev; 2003 ; 4(4):CD001751. PubMed ID: 14583938
[Link]; page 250
Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. Hurskainen R, JAMA; 2004 Mar 24 ; 291(12):1456-63. PubMed ID: 15039412
[Link]; page 253
A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Rapkin A. Psychoneuroendocrinology; 2003 Aug ; 28 Suppl 3():39-53. PubMed ID: 12892989
[Link]; page 254
Selective serotonin reuptake inhibitors for premenstrual syndrome. Wyatt K. Cochrane Database Syst Rev; 2002 ; (4):CD001396. PubMed ID: 12519554
[Link]; page 254
Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder. Freeman E. CNS Drugs; 2004 ; 18(7):453-68. PubMed ID: 15139800
[Link]; page 254
Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome. Cronje W. Hum Reprod; 2004 Sep ; 19(9):2152-5. PubMed ID: 15229203
[Link]; page 254
Breast cancer and hormone-replacement therapy in the Million Women Study. Beral V, Million Women Study Collaborators . Lancet; 2003 Aug 9 ; 362(9382):419-27. PubMed ID: 12927427
[Link]; page 257
Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study. Banks E, BMJ; 2004 Aug 28 ; 329(7464):477. PubMed ID: 15331472
[Link]; page 257
Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action. Sporn M. Clin Ther; 2004 Jun ; 26(6):830-40. PubMed ID: 15262454
[Link]; page 257
Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Scarabin P, EStrogen and THromboEmbolism Risk Study Group . Lancet; 2003 Aug 9 ; 362(9382):428-32. PubMed ID: 12927428
[Link]; page 257
Link page 257 no longer available
Link page 259 no longer available
Link page 259 no longer available
Link page 260 no longer available
Link page 261 no longer available
BMJ 1997;314:253 (25 January) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). R Rai
[Link]; page 261
Guidelines for the management of lichen sclerosus. Neill SM, British Association of Dermatologists . Br J Dermatol; 2002 Oct ; 147(4):640-9. PubMed ID: 12366407
[Link]; page 266
Link page 266 no longer available
Liquid-based cytology: the new screening test for cervical cancer control. McGoogan E. J Fam Plann Reprod Health Care; 2004 Apr ; 30(2):123-5. PubMed ID: 15087002
[Link]; page 270
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Harper DM. Lancet; 2004 Nov 13 ; 364(9447):1757-65. PubMed ID: 15541
[Link]; page 272
Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. Moreno V, International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group . Lancet; 2002 Mar 30 ; 359(9312):1085-92. PubMed ID: 11943255
[Link]; page 272
Actas Urol Esp. 1989 Sep-Oct;13(5):343-6 (Spanish). Viladoms Fuster JM. [Human papilloma virus in the male]
[Link]; page 272
Cervical cancer. Waggoner SE. Lancet; 2003 Jun 28 ; 361(9376):2217-25. PubMed ID: 12842378
[Link]; page 272
The cervical cancer epidemic that screening has prevented in the UK. Author: Peto J. Journal: Lancet; 2004 Jul 17 ; 364(9430):249-56. PubMed ID: 15262102
[Link]; page 273
Pelvic tuberculosis: an uncommon gynaecological problem presenting as ovarian mass. Sinha P, BJOG; 2000 Jan ; 107(1):139-40. PubMed ID: 10645876
[Link]; page 274
Ultrasonographic evaluation of the endometrium in postmenopausal vaginal bleeding. Davidson K .Radiol Clin North Am; 2003 Jul ; 41(4):769-80. PubMed ID: 12899491
[Link]; page 274
Link page 275 no longer available
Nat Genet. 2002 Apr;30(4):406-10. Epub 2002 Feb 25. Tomlinson IP. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
[Link]; page 276
[Link]; page 276
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. Palomba S,. J Clin Endocrinol Metab; 2002 Oct ; 87(10):4476-81. PubMed ID: 12364422
[Link]; page 276
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. Palomba S. Hum Reprod; 2002 Dec ; 17(12):3213-9. PubMed ID: 12456626
[Link]; page 276
Reproductive performance before and after abdominal myomectomy: a retrospective analysis. Marchionni M,. Fertil Steril; 2004 Jul ; 82(1):154-9, quiz 265. PubMed ID: 15237005
[Link]; page 276
Link page 282 no longer available
Biology of epithelial ovarian cancer: implications for screening women at high genetic risk. Hogg R, Friedlander M. J Clin Oncol; 2004 Apr 1 ; 22(7):1315-27. PubMed ID: 15051780
[Link]; page 283
Screening postmenopausal women for ovarian cancer: a systematic review.Fung M, Cancer Care Ontario Practice Guidelines Initiative Gynecology Cancer Disease Site Group .J Obstet Gynaecol Can; 2004 Aug ; 26(8):717-28. PubMed ID: 15307976
[Link]; page 283
Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience. Dizon D. Gynecol Oncol; 2003 Dec ; 91(3):584-90. PubMed ID: 14675681
[Link]; page 283
A comparative study of clinical management strategies for vaginal discharge in family planning and genitourinary medicine settings. Author: Melville C, Nandwani R, Bigrigg A, McMahon AD. Journal: J Fam Plann Reprod Health Care; 2005 Jan ; 31(1):26-30. PubMed ID: 15720844
[Link]; page 284
Link page 284 no longer available
Link page 286 no longer available
Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies. Adams E, Sex Transm Infect; 2004 Oct ; 80(5):354-62. PubMed ID: 15459402
[Link]; page 287
An evaluation of economics and acceptability of screening for Chlamydia trachomatis infection, in women attending antenatal, abortion, colposcopy and family planning clinics in Scotland, UK. Norman JE, BJOG; 2004 Nov ; 111(11):1261-8. PubMed ID: 15521872
[Link]; page 287
Emotional aspects of endometriosis: a physician's perspective. Author: Jones KP. Journal: Clin Obstet Gynecol; 1988 Dec ; 31(4):874-82. PubMed ID: 3229043.
[Link]; page 288
The use of thermal biofeedback in the treatment of pain associated with endometriosis: preliminary findings. Author: Hawkins RS, Hart AD. Journal: Appl Psychophysiol Biofeedback; 2003 Dec ; 28(4):279-89. PubMed ID: 14686081
[Link]; page 288
Hum Reprod. 2002 Mar;17(3):555-9. Stefansson H. Genetic factors contribute to the risk of developing endometriosis.
[Link]; page 290
Adriana Iliescu became pregnant after receiving fertility treatment for nine years.
[Link]; page 294
Emergency contraception: latest changes. Webb AM.J Fam Plann Reprod Health Care; 2004 Jan ; 30(1):7-9.
[Link]; page 299
Evra--a patch on oral contraception? Drug Ther Bull; 2003 Dec ; 41(12):89-91. PubMed ID: 14723093
[Link]; page 304
New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra). Faculty of Family Planning and Reproductive Health Care Clinical Effectiveness Unit . J Fam Plann Reprod Health Care; 2004 Jan ; 30(1):43-5. PubMed ID: 15006313
[Link]; page 304
A pilot open label study of Cystoprotek(R) in interstitial cystitis. Journal: Int J Immunopathol Pharmacol; 2005 January-March ; 18(1):183-188
[Link]; page 306
Improved quality of life in patients with overactive bladder symptoms treated with solifenacin n=1637. Author: Kelleher CJ, Cardozo L, Chapple CR, Haab F, Ridder AM. Journal: BJU Int; 2005 Jan ; 95(1):81-5. PubMed ID: 15638900
[Link]; page 307
Severe complications of hysterectomy: the VALUE study. McPherson K. BJOG; 2004 Jul ; 111(7):688-94. PubMed ID: 15198759
[Link]; page 308
Link page 308 no longer available
